Clinical Trial

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)

Study acronym: SDM-RCC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-09-19; most recent amendment 2025-05-12.
Status change: Not Yet Recruiting → Recruiting 2022-11-28
Trial Details
NCT Number NCT05548621
Lead Sponsor St. Antonius Hospital
Collaborators: Merck Sharp & Dohme LLC
Conditions Renal Cell Carcinoma, Renal Cell Carcinoma Metastatic
Enrollment 180 participants
Start Date 2022-11-24
Primary Completion 2025-09 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-15